JP2022548699A5 - - Google Patents

Info

Publication number
JP2022548699A5
JP2022548699A5 JP2022517393A JP2022517393A JP2022548699A5 JP 2022548699 A5 JP2022548699 A5 JP 2022548699A5 JP 2022517393 A JP2022517393 A JP 2022517393A JP 2022517393 A JP2022517393 A JP 2022517393A JP 2022548699 A5 JP2022548699 A5 JP 2022548699A5
Authority
JP
Japan
Prior art keywords
polymer
pharmaceutical composition
composition according
independently
polymer according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2022517393A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022548699A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/051506 external-priority patent/WO2021055759A1/en
Publication of JP2022548699A publication Critical patent/JP2022548699A/ja
Publication of JP2022548699A5 publication Critical patent/JP2022548699A5/ja
Priority to JP2025138954A priority Critical patent/JP2025168413A/ja
Withdrawn legal-status Critical Current

Links

JP2022517393A 2019-09-20 2020-09-18 置換フェニルボロン酸含有ポリマーおよび使用方法 Withdrawn JP2022548699A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025138954A JP2025168413A (ja) 2019-09-20 2025-08-22 置換フェニルボロン酸含有ポリマーおよび使用方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962903328P 2019-09-20 2019-09-20
US62/903,328 2019-09-20
PCT/US2020/051506 WO2021055759A1 (en) 2019-09-20 2020-09-18 Substituted phenyl boronic acid containing polymers and methods of use

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025138954A Division JP2025168413A (ja) 2019-09-20 2025-08-22 置換フェニルボロン酸含有ポリマーおよび使用方法

Publications (2)

Publication Number Publication Date
JP2022548699A JP2022548699A (ja) 2022-11-21
JP2022548699A5 true JP2022548699A5 (cg-RX-API-DMAC10.html) 2023-09-28

Family

ID=74884712

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022517393A Withdrawn JP2022548699A (ja) 2019-09-20 2020-09-18 置換フェニルボロン酸含有ポリマーおよび使用方法
JP2025138954A Pending JP2025168413A (ja) 2019-09-20 2025-08-22 置換フェニルボロン酸含有ポリマーおよび使用方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025138954A Pending JP2025168413A (ja) 2019-09-20 2025-08-22 置換フェニルボロン酸含有ポリマーおよび使用方法

Country Status (11)

Country Link
US (7) US11576928B2 (cg-RX-API-DMAC10.html)
EP (1) EP4031553A4 (cg-RX-API-DMAC10.html)
JP (2) JP2022548699A (cg-RX-API-DMAC10.html)
KR (1) KR20220065812A (cg-RX-API-DMAC10.html)
CN (1) CN114423768A (cg-RX-API-DMAC10.html)
AU (1) AU2020348451A1 (cg-RX-API-DMAC10.html)
BR (1) BR112022004981A2 (cg-RX-API-DMAC10.html)
CA (1) CA3150057A1 (cg-RX-API-DMAC10.html)
IL (2) IL291462B2 (cg-RX-API-DMAC10.html)
MX (1) MX2022003384A (cg-RX-API-DMAC10.html)
WO (1) WO2021055759A1 (cg-RX-API-DMAC10.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2022548699A (ja) 2019-09-20 2022-11-21 グライセンド， インコーポレイテッド 置換フェニルボロン酸含有ポリマーおよび使用方法
JP7850020B2 (ja) * 2022-06-28 2026-04-22 富士フイルム株式会社 高分子化合物、組成物、光学フィルムおよび光学積層体
CN116333197A (zh) * 2023-04-12 2023-06-27 厦门君德医药科技有限公司 胃肠道粘膜性聚合物、组合物及制备方法和应用
CN118593732B (zh) * 2024-06-27 2025-03-11 华中科技大学同济医学院附属同济医院 一种心肌炎核素分子探针及其制备方法和应用

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05310844A (ja) * 1992-05-08 1993-11-22 Nippon Oil & Fats Co Ltd フェニルボロン酸基含有重合体
JP3427447B2 (ja) * 1993-11-05 2003-07-14 日本油脂株式会社 フッ素化フェニルボロン酸基含有重合体
JPH07304971A (ja) 1994-05-09 1995-11-21 Nippon Oil & Fats Co Ltd 糖応答性高分子材料
US6221425B1 (en) * 1998-01-30 2001-04-24 Advanced Cardiovascular Systems, Inc. Lubricious hydrophilic coating for an intracorporeal medical device
JP3867400B2 (ja) * 1998-05-08 2007-01-10 日本油脂株式会社 ボロン酸基含有単量体およびその重合体
AU7856200A (en) 1999-10-07 2001-05-10 University Of Maryland Sugar binding polymers and the use thereof
US7998412B2 (en) 2000-01-07 2011-08-16 Smart Holograms Limited Ophthalmic device comprising a holographic sensor
US7041280B2 (en) 2001-06-29 2006-05-09 Genzyme Corporation Aryl boronate functionalized polymers for treating obesity
EP1534347B1 (en) 2002-07-22 2009-12-02 Psimei Pharmaceuticals Plc Conjugates of n-hydroxypropymethacrylamide-methacrylate copolymer with nuclide activation agent and/or anti-cancer compounds
AU2003291567A1 (en) 2002-11-19 2004-06-15 Genzyme Corporation Polymeric boronic acid derivatives as lipase inhibitors
GB0305587D0 (en) 2003-03-11 2003-04-16 Smart Holograms Ltd Sensor
CN101974125B (zh) 2004-07-30 2013-09-18 巴斯夫欧洲公司 聚合物硼酸衍生物及其在造纸中的用途
JP2007177014A (ja) 2005-12-27 2007-07-12 Kawamura Inst Of Chem Res ホウ酸塩基含有アリルアミン重合体
WO2008028193A2 (en) * 2006-09-01 2008-03-06 Pharmion Corporation Colon-targeted oral formulations of cytidine analogs
KR101466071B1 (ko) * 2007-05-21 2014-11-27 루브리졸 어드밴스드 머티어리얼스, 인코포레이티드 폴리우레탄 중합체
EP2226075A1 (en) * 2007-11-22 2010-09-08 The University of Tokyo Material for preventing tissue adhesion and material for preventing joint contracture
US8956556B2 (en) * 2008-07-02 2015-02-17 Eaton Corporation Dielectric isolators
KR20110059750A (ko) 2008-09-02 2011-06-03 유에스브이 리미티드 가교 폴리머
JP5622188B2 (ja) * 2010-01-05 2014-11-12 独立行政法人物質・材料研究機構 フェニルボロン酸系単量体及びフェニルボロン酸系重合体
BR112012021448A2 (pt) 2010-02-24 2016-05-31 Relypsa Inc polímero de amina, método para tratar doença, método de remoção de sais biliares de um indivíduo animal, método para melhorar o controle glicêmico em um indivíduo, e, processo para preparar o polímero de amina.
RU2017106587A (ru) 2010-02-24 2019-01-21 Релипса, Инк. Аминосодержащие полимеры для применения в качестве секвестрантов желчных кислот
ES2549513T3 (es) 2010-02-24 2015-10-28 Relypsa, Inc. Polivinilamina, polialilamina y polietilenimina reticuladas para uso como secuestradores de ácidos biliares
JP5696961B2 (ja) 2010-05-26 2015-04-08 独立行政法人物質・材料研究機構 糖応答性ゲル及び薬剤投与デバイス
JP5398017B2 (ja) 2010-07-22 2014-01-29 国立大学法人 東京大学 検出デバイス及びバイオセンサ
WO2012027331A1 (en) * 2010-08-27 2012-03-01 Ironwood Pharmaceuticals, Inc. Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders
EP2711774B1 (en) 2011-05-20 2017-03-29 Nissan Chemical Industries, Ltd. Photosensitive resin composition
US9730637B2 (en) 2011-08-19 2017-08-15 The Regents Of The University Of California Layered particles for retrieving DNA released from cells from a gastrointestinal tract sample and methods for making and using them
EP2781536B1 (en) 2011-11-17 2016-08-17 The University of Tokyo Block copolymer having phenylboronic acid group introduced therein, and use thereof
US9566299B2 (en) 2013-02-08 2017-02-14 Wockhardt Limited Oral pharmaceutical composition of aliphatic amine polymer or salts thereof
WO2014151565A1 (en) 2013-03-15 2014-09-25 The Brigham And Women's Hospital, Inc. Compounds to modulate intestinal absorption of nutrients
US20160354509A1 (en) 2014-02-10 2016-12-08 The Johns Hopkins University Devices for and methods of treatment of metabolic syndromes
CN103865060B (zh) 2014-03-20 2016-06-29 江南大学 一种含有苯硼酸官能团的高分子助留助滤剂的制备方法及其应用
MA41202A (fr) * 2014-12-18 2017-10-24 Genzyme Corp Copolymères polydiallymine réticulé pour le traitement du diabète de type 2
US10683379B2 (en) * 2015-03-23 2020-06-16 Massachusetts Institute Of Technology Polymers, hydrogels, and uses thereof
US11090354B2 (en) * 2015-08-06 2021-08-17 The Johns Hopkins University Composition and method for treatment of metabolic disorders
US10973846B2 (en) 2015-09-24 2021-04-13 The Brigham And Women's Hospital, Inc. Water-activated mucoadhesive compositions to reduce intestinal absorption of nutrients
WO2017061435A1 (ja) 2015-10-06 2017-04-13 国立研究開発法人物質・材料研究機構 ビニルアルコール樹脂機能化方法並びにビニルアルコール樹脂機能化剤
WO2017070617A1 (en) 2015-10-21 2017-04-27 Case Western Reserve University Diol-modified insulin analogues containing a glucose-regulated conformational switch
CN108366960B (zh) * 2015-10-23 2022-04-19 国立大学法人东京医科齿科大学 药物递送装置
EP3390715B1 (en) 2015-12-14 2020-12-02 Ecolab USA Inc. Boronic acid containing polymers for papermaking process
EP3852768A4 (en) * 2018-09-20 2022-09-14 Glyscend, Inc. BORONIC ACID POLYMERS AND METHODS OF USE
EP4041740A4 (en) 2019-09-20 2023-10-25 Glyscend, Inc. BENZOXABOROLE POLYMERS AND METHODS OF USE
JP2022548699A (ja) 2019-09-20 2022-11-21 グライセンド， インコーポレイテッド 置換フェニルボロン酸含有ポリマーおよび使用方法

Similar Documents

Publication Publication Date Title
JP2022501483A5 (cg-RX-API-DMAC10.html)
EP4125896B1 (en) Treatment of type 2 diabetes with 2-[(4-{6-[(4-cyano-2-fluorobenzyl)oxy]pyridin-2-yl} piperidin-1-yl)methyl]-1-[(2s)-oxetan-2-ylmethyl]-1h-benzimidazole-6-carboxylic acid or a pharmaceutically salt thereof
CA2860669C (en) Compositions and methods for treating metabolic disorders
US10201511B2 (en) Compositions and methods for treating metabolic disorders
US9770422B2 (en) Compositions and methods for treating metabolic disorders
KR102229492B1 (ko) 바이구아나이드를 포함하는 지연-방출 조성물
US10159658B2 (en) Compositions comprising statins, biguanides and further agents for reducing cardiometabolic risk
WO2003075933A1 (en) Composition for reducing blood glucose and cholesterol
WO2013103384A1 (en) Biguanide compositions and methods of treating metabolic disorders
IL291462B1 (en) Modified phenyl boronic acid containing polymers and methods of use
CN116368141B (zh) 噻二唑酮衍生物及其作为ampk激动剂用于治疗糖尿病和相关疾病的用途
JP2022548698A5 (cg-RX-API-DMAC10.html)
US11974971B2 (en) Compositions and methods for treating metabolic disorders
WO2023228023A1 (en) Treatment of type 2 diabetes or weight management control with 2-((4-((s)-2-(5-chloropyridin-2-yl)-2-methylbenzo[d][1,3]dioxol-4-yl)piperidin-1-yl)methyl)-1-(((s)-oxetan-2-yl)methyl)-1h-benzo[d]imidazole-6-carboxylic acid or a pharmaceutically salt thereof
TWI234456B (en) Pharmaceutical composition for treatment of type 2 diabetes mellitus and conditions associated with diabetes mellitus
WO2025099561A1 (en) Oral controlled-release matrix formulations of 2-[(4-{6-[(4-cyano-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[(2s)-oxetan-2-ylmethyl]-1h-benzimidazole-6-carboxylic acid or a pharmaceutically salt thereof